Ignite Creation Date:
2025-12-25 @ 2:55 AM
Ignite Modification Date:
2026-02-20 @ 1:32 PM
Study NCT ID:
NCT02406833
Status:
COMPLETED
Last Update Posted:
2018-02-28
First Post:
2015-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy
Sponsor:
Isarna Therapeutics GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ISTH-01-111
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None